Lin Xiao

749 citations
57 papers · 513 indexed · h-index 14
Topics
Endometrial and Cervical Cancer Treatments (8 papers)Cancer-related molecular mechanisms research (6 papers)Colorectal Cancer Surgical Treatments (5 papers)
Partner nations
ChinaUnited StatesTaiwan

In The Last Decade

Lin Xiao

52 papers receiving 508 citations

Peers

Lin Xiao
Comparison fields: 5 of 94
  • Molecular Biology 248
  • Cancer Research 134
  • Oncology 107
  • Pulmonary and Respiratory Medicine 102
  • Surgery 41
Replace H. Bühler with:
H. Bühler Germany
Wen-Qing Huang China
Armina A. Kazi United States
Ilaria Craparotta Italy
Rehana Qureshi United States
Fang Xie China
Bicheng Nan United States
Mohamed Adam Canada
Yonghui Wu China
Lin Xiao relative to H. Bühler Germany H. Bühler's profile →
Citations per field
00.5×6.4×
H. Bühler · 1×
Citations per year

Countries citing papers authored by Lin Xiao

Since Specialization
Citations

This map shows the geographic impact of Lin Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xiao more than expected).

Fields of papers citing papers by Lin Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xiao. The network helps show where Lin Xiao may publish in the future.

Co-authorship network of co-authors of Lin Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Xiao. A scholar is included among the top collaborators of Lin Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Xiao. Lin Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 7
4 1
5 0
6 9
7 1
8 2
9 14
10 12
11 11
12 10
13 16
14 6
15 17
16 9
17 14
18 1
19 19
20
Analysis of the indication and influence factors of cesarean section in past 10 years
1

About Lin Xiao

Lin Xiao is a scholar working on Obstetrics and Gynecology, Oncology and Cancer Research, having authored 57 papers that have together received 513 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (8 papers), Cancer-related molecular mechanisms research (6 papers) and Colorectal Cancer Surgical Treatments (5 papers). The work is most often cited by research in Cancer Research (134 citations), Obstetrics and Gynecology (33 citations) and Oncology (107 citations). Lin Xiao has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Rongrong Jing, Jie Wang, Ming Cui, Shaoqing Ju, Liangdan Tang, Junying Tang, Yi Cao, Kim E. Light, Jing Zhang and Dwight R. Pierce. Their work appears in journals such as Journal of Biological Chemistry, Scientific Reports and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026